Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite

This publication has 41 references indexed in Scilit:

• Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells
  Proceedings of the National Academy of Sciences, 1999
• The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in mice
  Cancer Letters, 1998
• Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride.
  Clinical & Experimental Metastasis, 1997
• Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model
  Breast Cancer Research and Treatment, 1996
• Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA)
  International Journal of Cancer, 1995
• The crystal structure of the catalytic domain of human urokinase-type plasminogen activator
  Structure, 1995
• Urokinase-producing tumour growth in SCID mice inhibited by recombinant PAI-2
  Fibrinolysis, 1995
• Crystal structures of matrilysin-inhibitor complexes
  Biochemistry, 1995
• Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical Significance
  Biological Chemistry Hoppe-Seyler, 1992
• Invasion and metastasis: Biology and clinical potential
  Pharmacology & Therapeutics, 1991